ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 407335 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 407335; 2) Community: the network communities that were significantly associated with the response to NSC 407335; 3) Molecule: the relationships between components within communities and NSC 407335; 4) MDR: the compounds that were significantly associated with the NSC 407335.

NSC Compound Enrichment Correlation
NSC 145668 Cyclocytidine hydrochloride 0.0422011701988039 0.56167507
NSC 357704 Cyanomorpholinodoxorubicin 0.0422011701988039 0.57457248
NSC 616348 Irinotecan hydrochloride 0.0422011701988039 0.67055817
NSC 646127 6H-Pyrido[4,3-b]carbazole, 1,2-dihydro-2,5,9,11-tetra- methyl- 0.0422011701988039 0.079793783
NSC 659949 14-Bromo-7-O-(2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexo- pyranosyl)-4-demethoxydaunomycinone 0.0422011701988039 0.42702231
NSC 660636 2-[1-(4-(4'-acetophenone)piperazino)]-naphthazarin 0.0422011701988039 -0.0076299173
NSC 667545 Null 0.0422011701988039 0.20256538
NSC 673186 Null 0.0422011701988039 -0.029183625
NSC 681636 Camptothecin Derivative 0.0422011701988039 0.70393591
NSC 683558 Camptothecin Derivative 0.0422011701988039 0.70060251
Total:40  Current:26    [First] [Prev] [Next] [Last]